Document is current

Any future updates will be listed below

Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy

Crossref DOI link: https://doi.org/10.1007/s12020-014-0283-1

Published Online: 2014-06-01

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark